Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease
Trial
N/A
Completed
May 7, 2018
Parkinson's Disease Biomarker Program
Trial
N/A
Completed
May 6, 2018
PharmacoMRI of Parkinson Disease
Trial
N/A
Completed
May 2, 2018
DatScan With Prototype Collimator
Trial
N/A
Completed
May 1, 2018
Evaluation of Ronnie Gardiner Method in Individuals With Parkinson's Disease
Trial
N/A
Completed
May 1, 2018
Exergaming in Upper Extremities for Persons With Parkinson's Disease
Trial
N/A
Completed
April 23, 2018
Efficacy of Ethnodyne Visio in Parkinson's Disease
Trial
N/A
Completed
April 17, 2018
Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease
Trial
Phase 2
Unknown
April 16, 2018
Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs
Trial
N/A
Completed
April 16, 2018
Sleep Homeostasis in Parkinson's Disease
Trial
N/A
Completed
April 8, 2018
Freezing of Gait: Clinical, Cognitive, and Imaging Features
Trial
N/A
Completed
April 5, 2018
Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism
Trial
N/A
Unknown
April 4, 2018
In Vivo Imaging of Therapeutic Electric Current Flow
Trial
N/A
Completed
April 4, 2018
Shanghai Parkinson's Study
Trial
N/A
Completed
April 4, 2018
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
Trial
Phase 2
Completed
April 4, 2018
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
Trial
Phase 3
Completed
April 3, 2018
Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease
Trial
N/A
Completed
April 3, 2018
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Trial
Phase 3
Completed
April 1, 2018
Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
Trial
Phase 2
Terminated
March 29, 2018
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
Trial
Phase 1
Terminated
March 28, 2018